Related Experiment Video
Updated: Jun 10, 2026
06:40
Visualization of Chondrocyte Intercalation and Directional Proliferation via Zebrabow Clonal Cell Analysis in the Embryonic Meckel’s Cartilage
Published on: October 21, 2015
[Angiogenesis in cartilage tumors]
1Institut für Pathologie, Otto-von-Guericke-Universität, Leipziger Str. 44, 39120 Magdeburg. kalinski@med.ovgu.de
Der Pathologe
|July 28, 2010
Summary
Angiogenesis, the formation of new blood vessels, is crucial in cartilage tumors but absent in normal cartilage. This review details angiogenesis in enchondromas and chondrosarcomas, exploring hypoxia and interleukin-1β roles.
Area of Science:
- Oncology
- Vascular Biology
- Biochemistry
Context:
- Normal cartilage is avascular, while cartilage tumors exhibit angiogenesis.
- Understanding tumor angiogenesis is vital for developing targeted therapies.
- This review focuses on angiogenesis in various cartilage tumors.
Purpose:
- To review the principles of angiogenesis in cartilage tumors.
- To discuss differential morphological and molecular aspects of angiogenesis.
- To explore the effects of hypoxia and interleukin-1β on angiogenic signaling.
Summary:
- Angiogenesis is a key feature distinguishing cartilage tumors from normal cartilage.
- The review covers enchondromas, conventional chondrosarcomas, and dedifferentiated chondrosarcomas.
- It examines the influence of hypoxia and interleukin-1β on chondrosarcoma cell signaling.
Impact:
- Provides insights into the mechanisms of cartilage tumor growth.
- Highlights potential therapeutic targets for treating cartilage tumors.
- Enhances understanding of tumor angiogenesis in a specific context.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:27Growth of Cartilage and Bone Tissue
Chondrocytes form a temporary cartilaginous model by dividing and secreting a thick gel-like extracellular matrix. Once the chondrocytes undergo programmed cell death, osteoblasts enter the site of the cartilaginous model. The process of replacing the temporary cartilaginous model with bone in an ordered manner is called endochondral ossification. In endochondral ossification, not all of the cartilage is replaced by bone tissue. Some cartilage that performs a protective and supportive function...
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...